Dashboard systems: Pharmacokinetic/pharmacodynamic mediated dose optimization for monoclonal antibodies.
about
Modeling and simulation in pediatric drug therapy: Application of pharmacometrics to define the right dose for children.Pharmacokinetic modeling of therapies for systemic lupus erythematosus.Immune Checkpoint inhibitors: An introduction to the next-generation cancer immunotherapy.Optimizing Treatment with TNF Inhibitors in Inflammatory Bowel Disease by Monitoring Drug Levels and Antidrug Antibodies.Considerations, challenges and future of anti-TNF therapy in treating inflammatory bowel disease.Drug Development of Therapeutic Monoclonal Antibodies.Clinical Pharmacokinetics and Pharmacodynamics of Biologic Therapeutics for Treatment of Systemic Lupus Erythematosus.Learning Health Systems as Facilitators of Precision Medicine.Individualized Infliximab Treatment Guided by Patient-managed eHealth in Children and Adolescents with Inflammatory Bowel Disease.Clinical performance of an infliximab rapid quantification assay.Therapeutic drug monitoring of CT-P13: a comparison of four different immunoassaysModel-Based Therapeutic Drug Monitoring of Infliximab Using a Single Serum Trough Concentration.Precision Dosing: Public Health Need, Proposed Framework, and Anticipated Impact.A Real-life Population Pharmacokinetic Study Reveals Factors Associated with Clearance and Immunogenicity of Infliximab in Inflammatory Bowel Disease.Therapeutic drug monitoring of vedolizumab in inflammatory bowel disease: current data and future directions.
P2860
Q38527434-4F7C06A1-99BD-4997-911F-90F1E36AB4B9Q38542910-3BA057A8-685B-48A1-BD41-9E42FD006A6EQ38548889-84B90DDA-0309-489A-8163-B01399A3B135Q38822920-4BDBB997-3607-4BB7-8E9C-C3C59C2A7C32Q38850063-18C6D973-566B-4629-8C14-91B7370153A9Q38876360-438693D9-5D2D-424B-9609-82BEE39DDA09Q38888137-84D64C6F-3AC1-408E-BC95-D8488C983078Q39041482-848266DD-18B3-4853-8445-865EFCA50905Q40159033-3645DBD3-7009-41E3-A957-798A826DE2EAQ41078459-A2EF7BB2-02F0-40F2-8C71-8A8230155F57Q41078498-724DF385-CB5D-41E5-B27B-221D755A3392Q47194271-719D4D22-8BFC-4B2B-B8C8-96F88037D112Q49171317-CB741D25-3916-406C-A5EB-A93E15A9E5D8Q53523796-BB514FBA-7B72-41CC-AA73-E3EE1490A8F2Q55258447-87075CBD-EE48-4695-9298-C8D4BBBCA87C
P2860
Dashboard systems: Pharmacokinetic/pharmacodynamic mediated dose optimization for monoclonal antibodies.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Dashboard systems: Pharmacokin ...... ion for monoclonal antibodies.
@en
type
label
Dashboard systems: Pharmacokin ...... ion for monoclonal antibodies.
@en
prefLabel
Dashboard systems: Pharmacokin ...... ion for monoclonal antibodies.
@en
P2860
P356
P1476
Dashboard systems: Pharmacokin ...... ion for monoclonal antibodies.
@en
P2093
Diane R Mould
Marla C Dubinsky
P2860
P356
10.1002/JCPH.370
P478
55 Suppl 3
P577
2015-03-01T00:00:00Z